Back to Search Start Over

Pseudomonas aeruginosa utilizes host polyunsaturated phosphatidylethanolamines to trigger theft-ferroptosis in bronchial epithelium

Authors :
Dar, Haider H.
Tyurina, Yulia Y.
Mikulska-Ruminska, Karolina
Shrivastava, Indira
Ting, Hsiu-Chi
Tyurin, Vladimir A.
Krieger, James
Croix, Claudette M. St.
Watkins, Simon
Bayir, Erkan
Mao, Gaowei
Armbruster, Catherine R.
Kapralov, Alexandr
Wang, Hong
Parsek, Matthew R.
Anthonymuthu, Tamil S.
Ogunsola, Abiola F.
Flitter, Becca A.
Freedman, Cody J.
Gaston, Jordan R.
Holman, Theodore R.
Pilewski, Joseph M.
Greenberger, Joel S.
Mallampalli, Rama K.
Doi, Yohei
Lee, Janet S.
Bahar, Ivet
Bomberger, Jennifer M.
Bayir, Hulya
Kagan, Valerian E.
Source :
Journal of Clinical Investigation. October 2018, Vol. 128 Issue 10, p4639, 15 p.
Publication Year :
2018

Abstract

Introduction Ferroptosis is a cell death program that is executed via activation of a selective enzymatic process of lipid peroxidation (LPO) catalyzed by 15-lipoxygenases (15LOXes), dioxygenases for polyunsaturated fatty acids [...]<br />Ferroptosis is a death program executed via selective oxidation of arachidonic acid-phosphatidylethanolamines (AA-PE) by 15-lipoxygenases. In mammalian cells and tissues, ferroptosis has been pathogenically associated with brain, kidney, and liver injury/diseases. We discovered that a prokaryotic bacterium, Pseudomonas aeruginosa, that does not contain AA-PE can express lipoxygenase (pLoxA), oxidize host AA-PE to 15-hydroperoxy-AA- PE (15-HOO-AA-PE), and trigger ferroptosis in human bronchial epithelial cells. Induction of ferroptosis by clinical P. aeruginosa isolates from patients with persistent lower respiratory tract infections was dependent on the level and enzymatic activity of pLoxA. Redox phospholipidomics revealed elevated levels of oxidized AA-PE in airway tissues from patients with cystic fibrosis (CF) but not with emphysema or CF without P. aeruginosa. We believe that the evolutionarily conserved mechanism of pLoxA-driven ferroptosis may represent a potential therapeutic target against P. aeruginosa- associated diseases such as CF and persistent lower respiratory tract infections.

Details

Language :
English
ISSN :
00219738
Volume :
128
Issue :
10
Database :
Gale General OneFile
Journal :
Journal of Clinical Investigation
Publication Type :
Academic Journal
Accession number :
edsgcl.558228202
Full Text :
https://doi.org/10.1172/JCI99490